Parkinson's drug may substantially reduce chemo side effects
CANCER DIGEST – Dec. 3, 2022 – Researchers have found that a drug already FDA-approved for treatment of Parkinson’s disease may reduce...
New immunotherapy approach promises to improve cancer outcomes
CANCER DIGEST – Nov. 19, 2022 – Researchers at Albert Einstein College of Medicine have identified an additional protein cancer cells use...
CT screening for early lung cancer leads to long-term survival
CANCER DIGEST – Nov. 27, 2022 – A new study shows that early detection of lung cancer with CT scanning dramatically increases long-term...
Metastasis-directed therapy may prolong progression-free survival in prostate cancer
CANCER DIGEST – Nov. 12, 2022 – For patients with prostate cancer that has spread to a single site outside the prostate, a therapy...
Adding drug to androgen suppression boosts progression-free survival in prostate cancer
CANCER DIGEST – Nov. 6, 2022 – An investigational therapy increased progression-free survival in 40 percent of nine patients whose...
Cancer deaths continue to decline
CANCER DIGEST – Oct. 29, 2022 – Cancer deaths in the US continued to decline between 2015 and 2019 according to the latest Annual Report...
